Clinical Trial Update: Verification Study on Lafutidine in Mild Reflux Oesophagitis - Double Blind Controlled Study With Famotidine - [Phase 3]

View source ↗

Summary

A Phase 3 verification study comparing lafutidine to famotidine for mild reflux esophagitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastroesophageal Reflux Disease

Drugs mentioned

• Famotidine (famotidine)
• Lafutidine (lafutidine)

Snippet

Sponsor: Taiho Pharmaceutical Co., Ltd. | Conditions: Gastroesophageal Reflux | Phase 3 | Status: COMPLETED